Drug Database
IN

INJEX system

✓ Approved

Equidyne · therapeutic agent

What is INJEX system?

INJEX system is a therapeutic agent developed by Equidyne. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection or subcutaneous injection.

Drug Profile

CompanyEquidyne
RouteInjectable (Others), Intramuscular (IM) Injection, Subcutaneous Injection
StatusApproved

Therapeutic Indications

INJEX system is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Surgical and medical proceduresOral appliance application✓ Approved

Related Research Articles

PubMedMedicine2026-09-19

An intelligent OCR-LLM prescription review system for inpatient narcotic and psychotropic drugs: Development and retrospective validation.

Ma Rong R, Xu Kai K, Zhang Mingming M, Li Xiangpeng X et al.

This study aimed to construct an intelligent prescription review system for inpatient narcotic and psychotropic drugs based on deep learning-based optical character recognition (OCR) and a local large language model (LLM) and evaluate its review performance and closed-loop management value. This study adopted a combined system development and retrospective validation design. Prescription images were first processed using OCR for text recognition and layout reconstruction. A local LLM was then applied to convert unstructured prescription text into standardized JavaScript Object Notation-formatted data. Subsequently, a locally developed rule base for narcotic and psychotropic drugs was used to evaluate prescription completeness, diagnosis-based dosage limits, medication instructions, physician signatures, and residual drug handling for injectable formulations. Using pharmacists' manual review results as the reference standard, 500 inpatient prescriptions for narcotic and psychotropic drugs were retrospectively included. System performance was evaluated in terms of accuracy, sensitivity, specificity, positive predictive value, negative predictive value, F1 score, and Cohen's kappa coefficient. The system successfully implemented prescription image recognition, text structuring, rule-based validation, signature verification, residual drug calculation, and triggers for manual pharmacist review. In the retrospective validation, compared with pharmacists' manual review, the system identified 144 true positives, 16 false positives, 334 true negatives, and 6 false negatives. The overall accuracy was 95.6%, sensitivity was 96.0%, specificity was 95.4%, positive predictive value was 90.0%, negative predictive value was 98.2%, F1 score was 0.929, and Cohen's kappa coefficient was 0.897. The proposed OCR-LLM-based intelligent prescription review system for inpatient narcotic and psychotropic drugs demonstrates high accuracy and strong consistency. It can serve as a front-end screening and decision-support tool for pharmacists and provides technical support for standardized, traceable, and closed-loop management of specially controlled medications.

PubMedCancer medicine2026-09-19

Schwann Cells in Physical Nerve Injury and Tumor Perineural Invasion: A Functional Overview and Comparison.

Zheng Yanni Y, Chen Xin X, Liu Jiachen J, Chen Jiayi J et al.

The nervous system exhibits remarkable stability, making its repair challenging. Compared to the central nervous system, peripheral nerve injuries demonstrate a greater potential for regeneration. Schwann cells, the unique myelinating glial cells of the peripheral nervous system, possess striking plasticity and support nerve regeneration through phenotypic transformation following injury. While Schwann cells are essential for nerve regeneration after injury, in the context of tumors, their reparative function is exploited to facilitate perineural invasion and the progression of cancer. However, the tumor-promoting effect of Schwann cells is context-dependent, and emerging evidence suggests that under specific conditions, Schwann cells may exert tumor-suppressive functions. This article aims to explore the complex roles of Schwann cells in both physical nerve injury and tumor-induced nerve damage, comparing their similarities and differences and seeking to provide insights for future research and potential therapeutic interventions.

PubMedInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026-09-19

Sexual health in patients with Turner syndrome: Outcomes from patient-reported outcomes measurement information system survey and body image scale.

Boedeker David D, Hunkler Kiley K, Welch Eva E, Neumann Brooke B et al.

PubMedAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists2026-09-19

Summarizing the evidence on health-system impacts of smart pump interoperability: A scoping review.

Glashan Elizabeth V EV, Nguyen Linh L, Xiong Shi Yi SY, Kung Janice Y JY et al.

Smart pump interoperability integrates infusion pumps with a healthcare facility's electronic health record to reduce the risk of intravenous medication errors. The purpose of this scoping review was to summarize and characterize the literature regarding health-system impacts from implementation of smart pump interoperability and identify gaps in research. A literature search was designed in collaboration with a medical librarian. Articles that studied impacts from implementation of smart pump interoperability in the acute care setting were identified. The following databases were searched from inception to 2025: MEDLINE, Embase, PubMed, Cochrane Library, CINAHL, Scopus, and TRIP (Turning Research Into Practice). The first 200 results from Google Scholar and bibliographies from included articles were screened. A structured search for gray literature was performed in Google. Data relating to the research question was extracted from each included article using a standardized data charting tool. Extracted data was analyzed descriptively to characterize the literature. Using predefined eligibility criteria, 1,452 titles and abstracts were screened, and 82 articles were selected for full-text review. Thirteen articles were included in this review. Varying study designs and methods have been used to examine health-system impacts resulting from the implementation of smart pump interoperability. Outcomes relating to patient safety, organizational finances, workflow and staff perception, documentation, and infusion data have been studied. Implementation is complex. Challenges to implementation and corresponding solutions have been detailed in the literature. Long-term studies with large sample sizes would strengthen the evidence regarding health-system impacts from smart pump interoperability.

PubMedFrontiers in public health2026-09-19

Advancing digital health in low-middle-income countries: experiences from Armenia's health system digital transformations.

Sargsyan Tsaghkanush T, Artsruni Anna A, Sargsyan Sergey S, Movsesyan Ruzanna R et al.

Digital health systems and the implementation of those systems in low- and middle-income countries (LMICs) can measurably enhance and facilitate systematic healthcare efficiency; though, it is often challenged by infrastructural and socioeconomic limitations. Republic of Armenia has recently fast-tracked healthcare digitalization as part of broader health system reforms. To describe experience and lessons learned from the implementation of the country-level E-health system, including barriers and solutions relevant to LMIC settings. A review of National policies, established digital health infrastructure, and existing practices; data were also gathered from country health system reports. The full-scale roll-out of the national-level electronic health network, called ARMED, empowered the extension of digital healthcare services-including all reporting systems, e-prescription workflow, registries, screening programs, and telemedicine. Implementation improved continuity of care and access to services, particularly in rural areas. Major challenges included fragmented health information, limited infrastructure, workforce and digital literacy gaps, and persistent rural-urban inequalities. Addressing these barriers required centralized governance, regulatory reforms, workforce training, and context-specific implementation approaches. The experience of Armenia can serve as an evocative guide, with practical steps for LMIC countries to fill gaps and tackle challenges. Experience in digital health governance can help fill gaps and strengthen the ability to use one's own systems to achieve health equity. The experience of Armenia clearly shows the impact of sustained governance, infrastructure development, and inclusive implementation strategies as critical factors for functional digital health implementation and transformation from paper to e-health in LMICs and can act for other countries pursuing equitable and scalable digital health integration as a well-documented case study.

PubMedFrontiers in medicine2026-09-19

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Tu Jiachen J, Wang Zhe Z, Zhang Jingjing J, Xu Haojie H et al.

The development of Bruton's tyrosine kinase (BTK) inhibitors has revolutionized the management of B-cell malignancies and holds potential in autoimmune diseases. However, safety concerns remain regarding treatment-associated adverse events: first-generation ibrutinib has been associated with off-target adverse event profiles, second-generation agents (acalabrutinib and zanubrutinib) require further validation of long-term safety patterns, and the real-world safety characteristics of third-generation pirtobrutinib continue to be evaluated. This study aims to characterize differences in adverse event (AE) disproportionality reporting signal patterns among four BTK inhibitors using data from the FDA Adverse Event Reporting System (FAERS). This study analyzed AE reports for four BTK inhibitors from the FAERS database via disproportionality analysis with four distinct algorithms, complemented by a clinical prioritization scoring system. Disproportionality reporting signal patterns were characterized across System Organ Class (SOC), Preferred Term (PT), and temporal distribution dimensions. A standardized 2-year observation window was applied for sensitivity analysis, and AE-mortality associations were evaluated. A total of 77,014 AE reports were included in this study. The four BTK inhibitors showed positive disproportionality reporting signals in blood and lymphatic system disorders, cardiac disorders, and infections and infestations. However, distinct disproportionality signal patterns were observed at the PT level. Ibrutinib showed prominent cardiovascular-related disproportionality reporting signals, particularly for atrial fibrillation (ROR = 9.8). Acalabrutinib was characterized by a distinct headache signal. Zanubrutinib showed prominent signals for myelosuppression (ROR = 16.24) and haemorrhage subcutaneous (ROR = 146.81). Pirtobrutinib demonstrated the strongest signal for increased white blood cell count (ROR = 54.28). Descriptive analysis of reported time-to-onset distributions showed that pneumonia reports for ibrutinib represented a larger proportion among cases reported after longer treatment durations, whereas haemorrhage and decreased white blood cell count reports were more frequently observed within earlier reporting intervals. In terms of fatal outcomes, multiple PTs associated with ibrutinib showed statistically significant associations with reported death outcomes within the FAERS dataset. This descriptive pharmacovigilance study identified distinct disproportionality reporting signal patterns for four BTK inhibitors based on FAERS data, providing potential signals for post-marketing safety surveillance. These findings should be interpreted as differences in reporting patterns.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about INJEX system